The second quarter of 2026 continued a busy year for the FDA, with notable new drug approvals, expanded indications, and key regulatory decisions that will impact patient care. For community pharmacies, these updates go beyond adding new medications to the shelf—they influence patient counseling, formulary and reimbursement considerations, inventory planning, and clinical decision-making. Staying informed […]